Enzymotec announced today the expansion of its line of products for dietary supplements, with the new product Crill™.

Crill™ is a phospholipids-based product, richer in DHA than Krill Oil, and offered at a competitive price. Crill™ is part of wide line of phospholipids offered by Enzymotec.

Dr. Ariel Katz, Enzymotec CEO says "the market is willing to get added value DHA with a better delivery system. Enzymotec developed the new bio-functional ingredient to address the market needs."

"Enzymotec has a proven track record of high quality products and services, as well as advanced technology and R&D capabilities. This product reflects our capabilities in producing tailor made solutions for customers who are looking for a source richer in DHA than Krill," added Dr. Kats.

Enzymotec is a developer and manufacturer of innovative, lipid-based biofunctional ingredients for dietary supplements, clinical nutrition and advanced infant nutrition. Key products include; the SharpŸPS® line of products, phosphatidylserine based ingredients for cognitive improvement, InFat®, structured fat for infant formulas, Krill Oil+™ and CardiaBeat®.